Repositioning Salirasib as a new antimalarial agent
Malaria is a serious tropical disease that kills thousands of people every year, mainly in Africa, due to Plasmodium falciparum infections. Salirasib is a promising cancer drug candidate that interferes with the post-translational modification of Ras. This S-farnesyl thiosalicylate inhibits isopreny...
Guardado en:
| Autores principales: | Porta, Exequiel Oscar Jesús, Bofill Verdaguer, Ignasi, Perez, Consuelo, Banchio, Claudia, Ferreira de Azevedo, Mauro, Katzin, Alejandro M., Labadie, Guillermo Roberto |
|---|---|
| Formato: | article artículo acceptedVersion |
| Lenguaje: | Inglés |
| Publicado: |
Royal Society of Chemistry
2020
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/2133/18278 http://hdl.handle.net/2133/18278 |
| Aporte de: |
Ejemplares similares
-
More on protein glycosylation in the malaria parasite (multiple letters) [1]
por: Kimura, E.A., et al. -
Characterization of the isoprenoid chain of coenzyme Q in Plasmodium falciparum
por: De Macedo, C.S., et al. -
More on protein glycosylation in the malaria parasite (multiple letters) [1]
por: Couto, Alicia Susana
Publicado: (2000) -
Characterization of the isoprenoid chain of coenzyme Q in Plasmodium falciparum
Publicado: (2002) -
Antimalarial activity of new acridinone derivatives
por: Fernández-Calienes, A., et al.